Research
Formulations
Mediprobe Healthcare formulations research is centered on developing multiple dosage forms and novel drug delivery systems which ensure better patient compliance.
Our key strength is that we have strong in-house R&D expertise, which has allowed us to develop a differentiated portfolio of pharmaceutical products that gives us a competitive advantage in the markets in which we operate.
We have a portfolio of 11 chiral molecules, of which six were the first to be launched in India, namely S-Amlodipine, S-Atenolol, Dexketoprofen Trometamol, Dexrabeprazole, S-Metoprolol Succinate and S-Pantoprazole Sodium Salt.
